Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma. | Cell Mol Biol Lett | 2022 | 36447138 | PubTator, text mining | PubMed |
| iDMET: network-based approach for integrating differential analysis of cancer metabolomics. | BMC Bioinformatics | 2022 | 36443658 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases in the acute leukemic signaling pathways. | Front Physiol | 2022 | 36439256 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes and Their Role in Breast Cancer Metastasis. | Int J Mol Sci | 2022 | 36430471 | PubTator, text mining | PubMed |
| Non-Coding RNAs of Extracellular Vesicles: Key Players in Organ-Specific Metastasis and Clinical Implications. | Cancers (Basel) | 2022 | 36428785 | PubTator, text mining | PubMed |
| Downregulating PDPK1 and taking phillyrin as PDPK1-targeting drug protect hepatocytes from alcoholic steatohepatitis by promoting autophagy. | Cell Death Dis | 2022 | 36418288 | PubTator, text mining | PubMed |
| GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: A review of pathobiology, therapies, and current models. | Front Hum Neurosci | 2022 | 36405075 | PubTator, text mining | PubMed |
| Virtual Screening and Network Pharmacology-Based Study to Explore the Pharmacological Mechanism of Clerodendrum Species for Anticancer Treatment. | Evid Based Complement Alternat Med | 2022 | 36387366 | PubTator, text mining | PubMed |
| Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. | Cell Rep Med | 2022 | 36384096 | PubTator, text mining | PubMed |
| Recent Progress in Regulation of Aging by Insulin/IGF-1 Signaling in Caenorhabditis elegans. | Mol Cells | 2022 | 36380728 | PubTator, text mining | PubMed |
| Collective genomic segments with differential pleiotropic patterns between cognitive dimensions and psychopathology. | Nat Commun | 2022 | 36369282 | PubTator, text mining | PubMed |
| Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery. | Int J Mol Sci | 2022 | 36361760 | PubTator, text mining | PubMed |
| Current Status and Prospects of Targeted Therapy for Osteosarcoma. | Cells | 2022 | 36359903 | PubTator, text mining | PubMed |
| Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment. | Cells | 2022 | 36359829 | PubTator, text mining | PubMed |
| The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance. | Cancers (Basel) | 2022 | 36358806 | PubTator, text mining | PubMed |
| Identification of NRAS Downstream Genes with CRISPR Activation Screening. | Biology (Basel) | 2022 | 36358254 | PubTator, text mining | PubMed |
| MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis. | Sci Rep | 2022 | 36344812 | PubTator, text mining | PubMed |
| The function and clinical implication of circular RNAs in lung cancer. | Front Oncol | 2022 | 36338714 | PubTator, text mining | PubMed |
| Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics. | Sci Rep | 2022 | 36335193 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=19